Levantinib in the Management of Differentiated Thyroid CancerByYujie Zhao, MD, PhDAugust 27th 2015Therapy that targets angiogenesis has been extensively investigated in differentiated thyroid cancer (DTC) and has demonstrated significant antitumor activity.